Chester County News and Community Website
GLENOLDEN, PA — The Charcot-Marie-Tooth Association has committed $100,000 to EverTree Bio, deepening its push to turn early scientific promise into potential treatments for Charcot-Marie-Tooth disease Type 1A, the most …
$100,000 Bet on Breakthrough: CMTA Backs Early CMT1A Drug Hope Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $300,000 investment in a groundbreaking gene editing project aimed at tackling CMT2A, the most common axonal type of Charcot-Marie-Tooth disease. The …
CMTA Invests $300,000 in Groundbreaking Gene Editing Therapy for CMT2A Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $90,860 investment in a groundbreaking two-year research project at the University of California, San Diego (UC San Diego). Led by Dr. …
CMTA Funds Breakthrough Research at UC San Diego on CMT2A Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $423,000 investment in the Solve-CMT initiative, a groundbreaking effort aimed at addressing diagnostic challenges and spurring new gene discoveries for Charcot-Marie-Tooth …
CMTA Invests $423,000 in Solve-CMT Initiative to Advance Gene Discovery Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has appointed David Skarinsky to its Strategy to Accelerate Research (STAR) Therapy Expert Board. This move comes as the organization intensifies its efforts …
Charcot-Marie-Tooth Association Appoints David Skarinsky to STAR Therapy Expert Board Read More GLENOLDEN, PA — The Charcot-Marie-Tooth Association (CMTA) has announced a $240,000 investment in gene replacement therapy targeting CMT4A, a severe form of the disease. This initiative, led by Dr. Xin …
CMTA Invests $240K in Gene Therapy for Rare Nerve Disorder Read More